|
SGP SpyGlass Pharma Inc 1778922 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-19,864,000.00 |
| Balance Sheet |
|
Current Assets
|
$236,461,000.00 |
|
Assets
|
$243,433,000.00 |
|
Current Liabilities
|
$9,437,000.00 |
|
Liabilities
|
$11,069,000.00 |
|
Equity
|
$232,364,000.00 |
|
Shares Out
|
33446315.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-28,383,000.00 |
|
Investing Cash Flow
|
$-2,600,000.00 |
| Market Analysis |
Market Cap
|
$877,296,842.45 |
|
Price
|
$26.23 |
|
BVPS
|
6.95 |
|
PB
|
3.77 |
|
EPS
|
-0.59 |
|
FCF
|
$-30,991,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:38 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:29 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-14 |
-0.69 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SGP documents filed with the SEC.
SGP Filings
Clear
